title: ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab.
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Nonomura
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Otsuka
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ohtsuka
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yamamoto
authors.affiliation: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: R
authors.initials: R
authors.lastname: Dummer
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.|Singapore Immunology Network (SIgN), Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.|PRESTO, Japan Science and Technology Agency, Saitama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000071096:ADAMTS Proteins / Q000378:metabolism*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008545:Melanoma / Q000378:metabolism*; D000077594:Nivolumab; D011565:Psoriasis / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab; D000071096:ADAMTS Proteins; C581035:ADAMTSL5 protein, human